Vinge advises SBB on its offer for Entra

Vinge advises Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) in connection with its public offer to the shareholders of Entra ASA.

Vinge advises on the sale of Word Audio Publishing International

Vinge has advised the sellers in connection with the sale of Word Audio Publishing International AB to Danish Gyldendal A/S

Vinge advised Investindustrial on its acquisition of Carl von Linnékliniken Group.

Carl von Linnékliniken Group is a leading fertility treatment clinic based in Uppsala offering various treatments such as IVF, IUI and gamete donation.

Vinge advises Re:NewCell on its IPO

Vinge advises Re:NewCell AB in connection with its listing on Nasdaq First North Premier Growth Market.

Vinge has advised Gränges in connection with its rights issue

Vinge has advised Gränges AB (publ) in connection with a fully guaranteed rights issue of approximately SEK 1.7 billion before transaction costs.

Vinge represents the owners of AppInConf Holding AB (“AppInConf”) in connection with the sale of the company to Invajo Techonlogies AB (publ) (“Invajo”)

AppInConf develops and provides mobile digital solutions for events and meetings and has historically been strong against e.g. medtech industry.

Vinge has advised VEF Ltd in connection with a directed share issue

Vinge has advised VEF Ltd, an investment company whose Swedish Depositary Receipts (“SDR”) are listed on Nasdaq First North, in connection with a directed share issue whereby VEF receives approximately SEK 522 million in issue proceeds.

Vinge has advised Nextory in connection with capital raising

Nextory has acquired SEK 165 million in a capital raising.

Vinge advises Main Capital in connection with the acquisition of PointSharp AB

PointSharp provides security solutions which enable enterprises to secure the login of their users to all their applications through e.g. multi-factor authentication, with a simplified user experience. PointSharp serves more than 220 customers globally.

Vinge has advised Pareto Securities in its capacity as Sole Manager and Bookrunner in connection with a directed share issue

Vinge has advised Pareto Securities in its capacity as Sole Manager and Bookrunner in connection with a directed share issue in the pharmaceutical company Xbrane Bipharma, whereby Xbrane Biopharma receives gross proceeds of approximately SEK 200 million.

Vinge advises Bridgepoint Growth in conjunction with the entry of a partnership in DCHud Holding AB

Diagnostiskt Centrum Hud, the leading provider of medical dermatology services in Sweden, partnered with Bridgepoint Growth to further support the company’s expansion.

Vinge represents the owners of Axel Arigato AB in connection with investment from Eurazeo

Vinge represents the owners of Axel Arigato AB in connection with Eurazeo Brands the investment from of EUR 56 million into the company.

Vinge has assisted STRAX in connection with a 30 MEUR facilities agreement with Proventus Capital Partners IV as lender

Vinge assisted the STRAX group in refinancing and the entering into a facilities agreement with Proventus Capital Partners IV (“Proventus”) as lender in the total amount of EUR 30 million.

Vinge advises BioGaia on directed share issue

Vinge advises BioGaia AB (publ) in connection with a directed share issue of approximately SEK 1.1 billion through an accelerated book-built offering.

Vinge has advised Alder II in conjunction with its investment in Briab

Briab is one of the leading fire safety engineering companies in Sweden.